Samlowski W - Search Results

1

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia.

Patel SP, Othus M, Chae YK, Dennis MJ, Gordon S, Mutch D, Samlowski W, Robinson WRR, Sharon E, Ryan C, Lopez G, Plets M, Blanke C, Kurzrock R. Patel SP, et al. Among authors: samlowski w. Clin Cancer Res. 2024 Jan 5;30(1):33-38. doi: 10.1158/1078-0432.CCR-23-2293. Clin Cancer Res. 2024. PMID: 37882676 Clinical Trial.

2

Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group phase II study.

Samlowski WE, Gundacker H, Kuebler JP, Giguere JK, Mills GM, Schuller DE, Ensley JF. Samlowski WE, et al. Invest New Drugs. 2001;19(4):311-5. doi: 10.1023/a:1010657609609. Invest New Drugs. 2001. PMID: 11561690 Clinical Trial.

3

From the guest editors: the dramatic advances in the treatment of metastatic renal cancer that have occurred over the last 3 years, with an eye toward the potential future directions of the field.

Samlowski WE, Vogelzang NJ. Samlowski WE, et al. Cancer J. 2008 Sep-Oct;14(5):286-7. doi: 10.1097/PPO.0b013e3181877ac5. Cancer J. 2008. PMID: 18836332 No abstract available.

4

Immunobiological consequences of acute and chronic UV exposure.

Daynes RA, Samlowski WE, Burnham DK, Gahring LC, Roberts LK. Daynes RA, et al. Among authors: samlowski we. Curr Probl Dermatol. 1986;15:176-94. doi: 10.1159/000412101. Curr Probl Dermatol. 1986. PMID: 2419038 Review. No abstract available.

5

Flecanide-induced immune neutropenia. Documentation of a hapten-mediated mechanism of cell destruction.

Samlowski WE, Frame RN, Logue GL. Samlowski WE, et al. Arch Intern Med. 1987 Feb;147(2):383-4. doi: 10.1001/archinte.147.2.383. Arch Intern Med. 1987. PMID: 2434046

6

Ultraviolet radiation and modulation.

Roberts LK, Lynch DH, Samlowski WE, Daynes RA. Roberts LK, et al. Among authors: samlowski we. Immunol Ser. 1989;46:167-215. Immunol Ser. 1989. PMID: 2488859 Review. No abstract available.

7

Primary treatment of verrucous carcinoma of the penis with fluorouracil, cis-diamino-dichloro-platinum, and radiation therapy.

Eliason M, Bowen G, Bowen A, Hazard L, Samlowski W. Eliason M, et al. Among authors: samlowski w. Arch Dermatol. 2009 Aug;145(8):950-2. doi: 10.1001/archdermatol.2009.160. Arch Dermatol. 2009. PMID: 19687438 No abstract available.

8

Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2.

Gill DM, Stenehjem DD, Parikh K, Merriman J, Sendilnathan A, Agarwal AM, Hahn AW, Gupta S, Tantravahi SK, Samlowski WE, Agarwal N. Gill DM, et al. Among authors: samlowski we. Ecancermedicalscience. 2016 Sep 29;10:676. doi: 10.3332/ecancer.2016.676. eCollection 2016. Ecancermedicalscience. 2016. PMID: 27729941 Free PMC article.

9

Cardiomyopathy associated with high-dose interleukin-2 therapy.

Beck AC, Ward JH, Hammond EH, Wray RB, Samlowski WE. Beck AC, et al. Among authors: samlowski we. West J Med. 1991 Sep;155(3):293-6. West J Med. 1991. PMID: 1949788 Free PMC article. No abstract available.

10

Phase II evaluation of mitoxantrone in advanced pancreatic carcinoma: a Southwest Oncology Group study.

Taylor SA, Fleming T, Von Hoff DD, McCracken JD, Bukowski RM, Talley RW, Natale RB, Guy JT, Samlowski WE, Costanzi JH. Taylor SA, et al. Among authors: samlowski we. Invest New Drugs. 1990 Feb;8(1):77-80. doi: 10.1007/BF00216928. Invest New Drugs. 1990. PMID: 2188928 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page